ArticleNeuro-oncology2025

Canonical amplifications and CDKN2A/B loss refine IDH1/2-mutant astrocytoma prognosis.

Hia S Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.